AIDS 2012 Focus: Integrated Prevention Campaigns

 

Program      Videos      Documents      Slides      News

Smiling Women

     

 

Satellite on Scaling Up of Integrated Prevention Campaigns, 25 July 2012

Overview

HIV/AIDS, diarrhea, and malaria cause 165 million DALYs per year, often co-located.

Integrated prevention campaigns (IPCs) can quickly and efficiently lessen the burden of these diseases.

In 2008, the Government of Kenya and partners implemented an IPC reaching 47,000 people in seven days with bed nets, water filters, and VCT. This pilot demonstrated that the IPC approach can help countries achieve HIV prevention and treatment goals.

This AIDS 2012 satellite session assessed the potential for global scale up of IPCs. The session had three panels. Panel #1 reviewed evidence for the health and economic effects of past integrated prevention campaigns, considering HIV, malaria, and diarrhea. Panel #2 presented data new data on the potential global impact of IPCs, examining opportunities by country, health effects, cost, and cost-effectiveness, and considering the role and challenges of multi-disease platforms and funding. Panel #3 considered issues around policy, funding, and sustainability.

 

 

Integrated Prevention Campaigns: Evidence for Impact and Efficiency, Global Applicability, and Sustainability

 

 

Organizers: UCSF (Institute for Health Policy Studies, Global Health Sciences, and the AIDS Research Institute), the National Institute on Drug Abuse, University of Washington, George Washington University, and Vestergaard Frandsen.

PROGRAM
 

Welcome (Video)

  • JG Kahn (UCSF)
  • P Hartsock (NIDA)

Evidence from past IPCs: implementation, costs, health impacts (Video)

IPC global applicability: potential coverage, health impacts, costs (Video)

Implications for policy and sustainability (Video)

  • Chair – J Sepulveda (UCSF)
  • Integrated care for HIV/AIDS and family planning – N. Sadik (UNAIDS)
  • Global Fund perspective – A Fakoya (Global Fund)
  • U.S. Office of Global AIDS Coordinator perspective – L Stabinski (OGAC)
  • Potential private sector roles – A De La Cruz (UCSF) [browse/download slides]
  • Innovation, high performance partnerships, and lessons from going to scale – M Vestergaard Frandsen (VF)
  • Closing remarks – G Greer (PMI)

Back

 

 

VIDEOS

Introduction & Session 2: Evidence from past IPCs: implementation, costs, health impacts

Session 2

Session 3

Top

 

 

 


 

 

 

DOCUMENTS

 

 

Abstracts

 

 

 


 

 

 

Posters

Top

 

 

SLIDES

 

 

Implementation – E Lugada (Axios)

 

 

Cost, health impact, cost-effectiveness – JG Kahn (UCSF)


 

 

 

 

Selection of priority geographic settings – J Walson (U Wash)

Back

 

 

Health impact and cost by setting and globally – E Marseille (Health Strategies Int’l)

Back

 

 

Stakeholder perspectives – E. Bendavid (Stanford)

Back

 

 

Opportunities and challenges of health delivery platforms – S Verguet (U Wash)

Back

 

 

Potential private sector roles – A De La Cruz (UCSF)

Back

 

 

 

 

 

News

 

NAM AIDSMAP: Preventing malaria and diarrhoea delays need for antiretroviral therapy

 

Top